##common.search##
##search.searchResults##
-
CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF PATIENTS WITH BENIGN PROSTATE HYPERPLASIA UNDER VARIOUS TECHNOLOGICAL TREATMENT APPROACHES
Benign prostatic hyperplasia (BPH) presents with clinical symptoms of LUTS (lower urinary tract symptoms), classified as storage symptoms (frequency, urgency) and voiding symptoms (weak stream, hesitancy), while its immunological characteristics include chronic inflammation and potential autoimmune reactions, with the degree of immune system involvement varying and potentially variable among patients. A total of 107 prostate specimens from elderly men with BPH who failed medical therapy and underwent transurethral resection of the prostate (TURP) between August 2022 and December 2025 were collected and retrospectively analyzed. The patients' ages ranged from 40 to 89 years, and the mean age was 71.28 ± 7.43 years. For each patient with BPH whose prostate was pathologically confirmed, complete clinical information was provided, including age, prostate volume, preoperative International Prostate Symptom Score (IPSS), quality of life (QOL) score, maximum urinary flow rate (Qmax), and bladder outlet obstruction index (BOOI).